CXS chemgenex pharmaceuticals ltd
Add to My Watchlist 0.00% ! 70.0¢

re: shall submit its 2nd part for nda

  1. biotechinvestor
    79 Posts.
    clock Created with Sketch.
    09/02/09
    21:47
    Post #: 4777437
    It is expected for CXS to submit its 2nd part of its NDA, CMC, to FDA by Q2 this year.

    IMO, now could be a good timing to invest CXS.
    CXS Price at posting: 35.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
NEWS New targets and high-grade intercepts drive Bullabulling drill expansion
right-arrow Created with Sketch.
AII Why Almonty Industries is THE tungsten mining stock to watch
right-arrow Created with Sketch.
NEWS The 4 sectors poised to benefit from Australia's immigration wave
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.